Effective January 11, 2016, IOmet Pharma is now a wholly owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada).
IOmet Pharma, a UK-based company, discovers and develops novel small molecules for the treatment of cancer. Our pipeline is focused on the exciting fields of cancer immunotherapy and cancer metabolism. IOmet Pharma currently has a number of programs at various stages of development, investigating innovative chemical matter to modulate exciting and novel targets.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Edinburgh Bioquarter, Edinburgh,united Kingdom
- Phone
- 44 7887 631 550
- in****@****rma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.iometpharma.com
- HQ
- Edinburgh
Iomet Pharma Questions
Iomet Pharma's helpline number is 44 7887 631 550
Iomet Pharma's website is http://www.iometpharma.com
Iomet Pharma's LinkedIn profile is https://uk.linkedin.com/company/iomet-pharma
Iomet Pharma has
1 employees.
View email and phone details for 1
employees at Iomet Pharma.
Iomet Pharma's industry is
Biotechnology Research
Iomet Pharma's top competitors are
Inventiva Pharma,
Invitro-Connect Gmbh - Laboratory Testing And Regulatory Services,
Innozell,
Max Aigner,
Intensichem Ltd,
Sitokine Ltd,
Marston Bridge Llp,
Ionctura,
Cxr Biosciences: The Investigative And Exploratory Toxicology Company (Now Concept Life Sciences),
Duke Street Bio.
Iomet Pharma's support email address is info@iometpharma.com
Iomet Pharma's categories are Biotechnology Research
Iomet Pharma's founding year is 2008
